Bangying Su

Corporate Officer/Principal bij Washington University in St. Louis

Consumer Services

Health Technology

Actieve functies van Bangying Su

Bedrijven	Functie	Begin	Einde
Washington University in St. Louis	Corporate Officer/Principal	25-01-2010	-
The University of Alabama	Corporate Officer/Principal	25-01-2010	-

Bedrijven	Functie	Begin	Einde
Dynamis Therapeutics, Inc. Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.	Corporate Officer/Principal	25-01-2010	-

Peking University

Undergraduate Degree

Internationaal

Verenigde Staten	4
China	2

Operationeel

Corporate Officer/Principal	3
Undergraduate Degree	1

Sectoraal

Consumer Services	4
Health Technology	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Bedrijven in privébezit	1
Dynamis Therapeutics, Inc. Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.	Health Technology

Bedrijven in privébezit

Health Technology